Price $53.55 |
Market Cap
539.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
38.3
|
P/B
3.19
|
P/S
1.31
|
Dividend %
-
|
|
P/CF
12.4
|
P/FCF
11.5
|
Op. Cash Flow
52.8K
|
FCF
4.2
|
|
Op. Margin
6.20%
|
Net Margin
3.20%
|
ROE
8.00%
|
ROI
8.70%
|
|
ROA
5.30%
|
EPS Growth
13.60%
|
Current Ratio
2.9
|
Debt/Equity
22.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $7.90 | - | - | 113.3M | Strong Buy |
| Digirad Corporation (DRAD) | $1.40 | - | 14.20% | 31.1M | Strong Buy |
| Tenet Healthcare Corp (THC) | $24.05 | - | - | 2.41B | Strong Buy |
| Depomed Inc (DEPO) | $6.79 | - | - | 415.3M | Strong Buy |
| Nephros, Inc. (NEPH) | $0.54 | - | - | 23.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
